EVERZOM
LIVE

Serial Number

79284229

Owner

EVERZOM

Attorney

Arnaud Rainfray

Filing Date

Mar 4, 2020

Add to watchlist:

No watchlists yet
View on USPTO

EVERZOM Trademark

Serial Number: 79284229 • Registration: 6248149

EVERZOM is a trademark filed by EVERZOM on March 4, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

EVERZOM

24 rue du Faubourg Saint-Jacques

Entity Type: 99

Trademark Details

Filing Date

March 4, 2020

Registration Date

January 19, 2021

Published for Opposition

November 3, 2020

Goods & Services

Medical research and pharmacological research services; analysis of human tissues for medical research purposes; pharmaceutical drug development services, namely, development of pharmaceutical preparations and medicines from extracellular vesicles; conducting clinical trials for others; provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials; medical research and laboratory services in the field of human tissue, namely, tissue engineering; medical research services, namely, clinical research in the field of biotherapy; conducting clinical trials for others, namely, carrying out clinical trials for pharmaceutical products; testing on pharmaceutical products; quality control for others, namely, quality evaluation of pharmaceutical products; research and development in the field of pharmaceuticals and biotechnology; medical research services, namely, biological, clinical and medical research services in the field of biotherapy; scientific research for medical purposes in the field of biotherapy; scientific research in the field of extracellular vesicles, namely, scientific research in the field of analysis, isolation and production of extracellular vesicles; laboratory research services concerning pharmaceutical products; stem cell research; scientific research and development in the field of microorganisms and cells; scientific research and development in the field of extracellular vesicles; scientific research services with respect to the isolation and cultivation of human cells and tissues

Medical services, namely, regenerative medicine services using extracellular vesicles; stem cell therapy services, namely, therapy services based on stem cells; biotherapy services, namely, health care therapy services for treating cancer, cardiovascular diseases, acute kidney injury, brain injury, liver injury, osteoarthrisis, bone regeneration, lung injury, cutaneous wound healing, fistula, stenosis, radio induced fibrosis, autoimmune diseases, lysosomal storage disorders, degenerative diseases, using extracellular vesicles; biotherapy services, namely, medical services relating to the collection, treatment and processing of human cells

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 19, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Dec 24, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 16, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 23, 2021 FICS
FINAL DISPOSITION PROCESSED
Apr 23, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 19, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 19, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 3, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 14, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 28, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 28, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 28, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 28, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 28, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 8, 2020 TROA
REFUSAL PROCESSED BY IB
Jul 18, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 1, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jun 30, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 31, 2020 RFCR
NON-FINAL ACTION WRITTEN
May 30, 2020 CNRT
ASSIGNED TO EXAMINER
May 21, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
May 5, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 30, 2020 REPR